Funder: Pfizer Inc.
Due Dates: April 7, 2026 (full application, 23:59 EST)
Funding Amounts: Up to $27,000 per project; total available budget $110,000; max duration 12 months
Summary: Supports research on the real-world effectiveness and safety of SUL-DUR for CRAB infection in special adult populations in China.
Key Information: PI and institution must be based in mainland China; only organizations (not individuals) are eligible.